Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy

Nature

Volumn 386, Issue 6627, 1997, Pages 847-851

  Lalioti, Maria D ^a   Scott, Hamish S ^a   Buresi, Catherine ^a   Rossier, Colette ^a   Bottani, Armand ^b   Morris, Michael A ^b   Malafosse, Alain ^a   Antonarakis, Stylianos E ^a,b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CEREBELLAR ATAXIA; GENE LOCUS; HUMAN; HUMAN CELL; MENTAL DEFICIENCY; MYOCLONUS EPILEPSY; POINT MUTATION; PRIORITY JOURNAL;

EID: 0030964106     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/386847a0     Document Type: Article

References (30)

1. Norio, R. & Koskiniemi, M. Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients. Clin. Genet. 15, 82-398 (1979).
2. Genton, P., Michelucci, R., Tassinari, C. A. & Roger, J. The Ramsay-Hunt syndrome revisited: Mediterranean myoclonus versus mitochondrial encephalomyopathy with ragged-red fibers and Baltic myoclonus. Acta Neurol. Scand. 81, 8-15 (1990).
3. Pennacchio, L. A. et al. Mutations in the gene encoding Cystatin B in progressive myoclonus epilepsy (EPM1). Science 271, 1731-1734 (1996).
4. Lalioti, M. D. et al. Identification of mutations in Cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1). Am. J. Hum. Genet. 60, 342-351 (1997).
5. Lafrenière, R. G. et al. Unstable insertion in the 5′ flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nature Genet. 15, 298-302 (1997).
6. Lehesjoki, A.-E. et al. Localisation of the EPM1 gene for progressive myoclonus epilepsy on chromosome 21: linkage disequilibrium allows high resolution mapping. Hum. Mol. Genet. 2, 1229-1234 (1993).
7. Dausset, J. et al. Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics 6, 575-577 (1990).
8. Talbot, C. C. et al. The tetranucleotide repeat polymorphism D21S1245 demonstrates hypermutabiity in germline and somatic cells. Hum. Mol. Genet. 4, 1193-1199 (1995).
9. Labauge, P. et al. Allelic heterogeneity of Mediterranean myoclonus. Ann. Neurol. (in the press).
10. Paulson, H. L. & Fischbeck, K. H. Trinucleotide repeats in neurogenetic disorders. Annu. Rev. Neurosci. 19, 79-107 (1996).
11. Ashley, C. T. & Warren, S. T. Trinucleotide repeat expansion and human disease. Annu. Rev. Genet. 29, 703-728 (1995).
12. Richards, R. I. & Sutherland, G. R. Dynamic mutations: a new class of mutations causing human disease. Cell 70, 709-712 (1992).
13. Campuzano, V. et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423-1427 (1996).
14. Yu, S. et al. Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell 88, 367-374 (1996).
15. Turk, V. & Bode, W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 285, 213-219 (1991).
16. Pieretti, M. et al. Absence of expression ofthe FMR-1 gene in fragile X syndrome. Cell 66, 817-822 (1991).
17. Gecz, J., Gedeon, A. K., Sutherland, G. R. & Mulley, J. C. Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet. 13, 105-108 (1996).
18. Gu, Y., Shen, Y., Gibbs, R. A. & Nelson, D. L. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nat. Genet. 13, 109-113 (1996).
19. Fu, Y.-H. et al. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 260, 235-238 (1993).
20. Sabouri, L. A. et al. Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene. Nature Genet. 4, 233-238 (1993).
21. Oberle, I. et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252, 1097-1102 (1991).
22. Knight, S. J. L. et al. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 74, 127-134 (1993).
23. Verkerk, A. J. et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914 (1991).
24. Brook, J.D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68, 799-808 (1992).
25. Mach, B., Steimle, V., Martinez-Soria, E. & Reith, W. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14, 301-331 (1996).
26. Levine, M. & Manley, J.-L. Transcriptional repression of eukaryotic promoters. Cell 59, 405-408 (1989).
27. Youssoufian, H. & Lodish, H. F. Transcriptional inhibition of the murine erythropoietin receptor gene by an upstream repetitive element. Mol. Cell. Biol. 13, 98-104 (1993).
28. Rawlings, N. D. & Barrett, A. J. Families of cysteine peptidases. Meth. Enzymol. 244, 461-486 (1994).
29. Takahashi, A. & Earnshaw, W. C. ICE-related proteases in apoptosis. Curr. Opin Genet. Dev. 6, 50-55 (1996).
30. Pennacchio, L. A. & Myers, R. M. Isolation and characterization of the mouse cystatin B gene. Genome Res. 6, 1103-1109 (1996).